WDB coco CoTSE:7079 -0.47%78 ROA % is 14.52% as of Mar. 2026, which is 34% below its 10-year median of 21.89. GuruFocus rates TSE:7079 with a GF Score™ of 78/100 and a GF Value™ of 円3,452.59 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 683 Healthcare Providers & Services companies, WDB coco Co ranks better than 91.8% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. WDB coco Co's annualizedNet Income for the quarter that ended in Mar. 2026 was 円800 Mil.
WDB coco Co's average Total Assets over the quarter that ended in Mar. 2026 was 円5,511 Mil. Therefore, WDB coco Co's annualized ROA % for the quarter that ended in Mar. 2026 was 14.52%.
The historical rank and industry rank for WDB coco Co's ROA % or its related term are showing as below:
TSE:7079'
s ROA % Range Over the Past 10 Years
Min: 12.03 Med: 21.89 Max: 25.93
Current: 12.27
During the past 9 years, WDB coco Co's highest ROA % was 25.93%. The lowest was 12.03%. And the median was 21.89%.
TSE:7079's ROA % is ranked better than 91.8% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.77
vs TSE:7079: 12.27
WDB coco Co (TSE:7079) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
WDB coco Co ROA % Related Terms
WDB coco Co ROA % Historical Data
* Premium members only.
The historical data trend for WDB coco Co's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, WDB coco Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WDB coco Co ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, WDB coco Co's ROA % distribution charts can be found below:
* The bar in red indicates where WDB coco Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
WDB coco Co (TSE:7079) has a ROA % of 14.52% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on WDB coco Co and its competitors. This is 34% below median its historical median of 21.89. Over the past decade, WDB coco Co's ROA % has ranged from 12.03 to 25.93. According to the industry distribution chart, WDB coco Co ranks #56 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 8.2%.
Is WDB coco Co's ROA % too high?
WDB coco Co's current ROA % of 14.52% is 34% below median its 10-year median of 21.89. Over the past 10 years, this metric has ranged from a low of 12.03 to a high of 25.93. The Healthcare Providers & Services industry median ROA % is 1.77. WDB coco Co's value of 14.52% is 720.3% above this industry median. Based on the distribution chart, WDB coco Co ranks #56 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, WDB coco Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WDB coco Co's ROA % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, WDB coco Co ranks #56 out of 683 companies for ROA %. This places WDB coco Co in the top 8% of its industry — outperforming the majority of peers. The industry median ROA % is 1.77. WDB coco Co's value of 14.52% is 720.3% above this benchmark. Historically, WDB coco Co's own ROA % has ranged from 12.03 to 25.93 over the past decade. While the company's 10-year median is 21.89 vs. the industry median of 1.77, WDB coco Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.77, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WDB coco Co's current ROA % of 14.52% is 720.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on WDB coco Co and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WDB coco Co's current ROA % is 14.52%, which is 34% below median its own 10-year median of 21.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WDB coco Co stock overvalued right now?
Based on GuruFocus' analysis, WDB coco Co (TSE:7079) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,452.59, compared to a current price of 円2,529.00 — trading 26.8% below its estimated fair value. The current ROA % is 14.52%, which is 34% below median its 10-year median of 21.89 and 720.3% above the Healthcare Providers & Services industry median of 1.77. WDB coco Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For WDB coco Co (TSE:7079), the current ROA % is 14.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WDB coco Co (TSE:7079) Overvalued in 2026?
Based on GuruFocus' analysis, WDB coco Co stock appears to be undervalued.
The current stock price of 円2,529.00 is trading 26.8% below its estimated GF Value™ of 円3,452.59.
GuruFocus considers WDB coco Co to be Modestly Undervalued.
Key valuation signals for TSE:7079:
ROA %: 14.52% (34% below median its 10-year median of 21.89)
GF Value™: 円3,452.59 vs. price of 円2,529.00 (26.8% below fair value)
Industry Position: 720.3% above the Healthcare Providers & Services median (#56 of 683)
No single metric tells the full story. See the TSE:7079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC-related work, PMS facility contract support related work, clinical research support/monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments, such as monitoring, safety information, data management, and statistical analysis. It provides support for the development of generic drugs, such as bioequivalence studies and biosimilars, clinical research, and physician-led clinical trials.
78GF Score
Get the complete analysis for TSE:7079
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7079 has been successfully added to your 
